世界の美容機器開発動向:医療機器パイプライン分析2015

◆英語タイトル:Aesthetic Devices - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0145EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年1月5日
◆ページ数:313
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、美容機器のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・美容機器の概要
・美容機器の開発動向:開発段階別分析
・美容機器の開発動向:セグメント別分析
・美容機器の開発動向:領域別分析
・美容機器の開発動向:規制Path別分析
・美容機器の開発動向:承認日(推定)別分析
・企業別美容機器の開発動向(パイプライン製品、進行中の治験)
・美容機器の最近動向
【レポートの概要】

Aesthetic Devices – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Aesthetic Devices – Medical Devices Pipeline Assessment, 2015″ provides an overview of Aesthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Aesthetic Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Aesthetic Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 15
2 Introduction 16
2.1 Aesthetic Devices Overview 16
3 Products under Development 17
3.1 Aesthetic Devices – Pipeline Products by Stage of Development 17
3.2 Aesthetic Devices – Pipeline Products by Segment 18
3.3 Aesthetic Devices – Pipeline Products by Territory 19
3.4 Aesthetic Devices – Pipeline Products by Regulatory Path 21
3.5 Aesthetic Devices – Pipeline Products by Estimated Approval Date 22
3.6 Aesthetic Devices – Ongoing Clinical Trials 23
4 Aesthetic Devices – Pipeline Products under Development by Companies 24
4.1 Aesthetic Devices Companies – Pipeline Products by Stage of Development 24
4.2 Aesthetic Devices – Pipeline Products by Stage of Development 27
5 Aesthetic Devices Companies and Product Overview 32
5.1 Advalight Company Overview 32
5.1.1 Advalight Pipeline Products & Ongoing Clinical Trials Overview 32
5.2 Aesthetic Medical Device Company Overview 33
5.2.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 33
5.3 Aesthetics Point Ltd. Company Overview 35
5.3.1 Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
5.4 AirXpanders, Inc. Company Overview 36
5.4.1 AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 Allergan, Inc. Company Overview 40
5.5.1 Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.6 Ambicare Health Ltd Company Overview 49
5.6.1 Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 Andrew Technology, LLC Company Overview 52
5.7.1 Andrew Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.8 Anika Therapeutics, Inc. Company Overview 53
5.8.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.9 Avita Medical Ltd Company Overview 55
5.9.1 Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.10 BioPhotas, Inc. Company Overview 60
5.10.1 BioPhotas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.11 BioPolymer GmbH & Co. KG Company Overview 62
5.11.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 62
5.12 Biosculpture Technology, Inc. Company Overview 66
5.12.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.13 Body Organ Biomedical Corp. Company Overview 68
5.13.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 Chromogenex Technologies Limited Company Overview 70
5.14.1 Chromogenex Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 Cozart plc Company Overview 71
5.15.1 Cozart plc Pipeline Products & Ongoing Clinical Trials Overview 71
5.16 Cynosure, Inc. Company Overview 72
5.16.1 Cynosure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.17 Cytophil, Inc. Company Overview 80
5.17.1 Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.18 Cytori Therapeutics, Inc. Company Overview 81
5.18.1 Cytori Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.19 Cytosial Biomedic, S.a.s. Company Overview 84
5.19.1 Cytosial Biomedic, S.a.s. Pipeline Products & Ongoing Clinical Trials Overview 84
5.20 Dermele Skin Care, LLC Company Overview 86
5.20.1 Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 86
5.21 Ellman International, Inc. Company Overview 87
5.21.1 Ellman International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.22 Erchonia Corporation Company Overview 88
5.22.1 Erchonia Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
5.23 Eternity Healthcare Inc. Company Overview 90
5.23.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.24 EternoGen, LLC Company Overview 91
5.24.1 EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview 91
5.25 Eve Aesthetics Ltd. Company Overview 92
5.25.1 Eve Aesthetics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.26 FibroGen, Inc. Company Overview 93
5.26.1 FibroGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.27 Forticell Bioscience, Inc. Company Overview 95
5.27.1 Forticell Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.28 Genethia Phrima SRL Company Overview 96
5.28.1 Genethia Phrima SRL Pipeline Products & Ongoing Clinical Trials Overview 96
5.29 Genzyme Corporation Company Overview 97
5.29.1 Genzyme Corporation Pipeline Products & Ongoing Clinical Trials Overview 97
5.30 Ilooda Co., Ltd. Company Overview 98
5.30.1 Ilooda Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 ImpLite Ltd. Company Overview 99
5.31.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 99
5.32 Innovia LLC Company Overview 100
5.32.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 100
5.33 Invasix Company Overview 102
5.33.1 Invasix Pipeline Products & Ongoing Clinical Trials Overview 102
5.34 Juvenis Ltd. Company Overview 106
5.34.1 Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.35 Keraderm LLC Company Overview 107
5.35.1 Keraderm LLC Pipeline Products & Ongoing Clinical Trials Overview 107
5.36 Khorionyx Company Overview 109
5.36.1 Khorionyx Pipeline Products & Ongoing Clinical Trials Overview 109
5.37 L&C Bio Company Overview 110
5.37.1 L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 110
5.38 Medifirst Solutions, Inc. Company Overview 111
5.38.1 Medifirst Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.39 Medixsysteme Company Overview 113
5.39.1 Medixsysteme Pipeline Products & Ongoing Clinical Trials Overview 113
5.40 Mentor Worldwide LLC Company Overview 117
5.40.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 117
5.41 Merz Pharma GmbH & Co. KgaA Company Overview 119
5.41.1 Merz Pharma GmbH & Co. KgaA Pipeline Products & Ongoing Clinical Trials Overview 119
5.42 Moma Therapeutics, Inc. Company Overview 121
5.42.1 Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.43 Mosaic Medical Technologies, Inc Company Overview 122
5.43.1 Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 122
5.44 Neosthetic, LLC Company Overview 123
5.44.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.45 NivaSonix, LLC Company Overview 124
5.45.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 124
5.46 Northwestern University Company Overview 125
5.46.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 125
5.47 Northwood Medical Innovation Limited Company Overview 126
5.47.1 Northwood Medical Innovation Limited Pipeline Products & Ongoing Clinical Trials Overview 126
5.48 Nu Skin International Inc. Company Overview 127
5.48.1 Nu Skin International Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.49 Oligo Medic, Inc. Company Overview 129
5.49.1 Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.50 ORGEV Laboratories Company Overview 130
5.50.1 ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview 130
5.51 Osyris Medical Company Overview 144
5.51.1 Osyris Medical Pipeline Products & Ongoing Clinical Trials Overview 144
5.52 Philips Healthcare Company Overview 145
5.52.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 145
5.53 PhotoDerma SA Company Overview 147
5.53.1 PhotoDerma SA Pipeline Products & Ongoing Clinical Trials Overview 147
5.54 PhotoMedex, Inc. Company Overview 149
5.54.1 PhotoMedex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.55 Pinnacle Therapeutics Company Overview 152
5.55.1 Pinnacle Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 PolyNovo Biomaterials Pty Ltd Company Overview 153
5.56.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 153
5.57 PS Advanced Engineering Company Overview 155
5.57.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 155
5.58 Rocky Mountain Biosystems Inc Company Overview 159
5.58.1 Rocky Mountain Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 159
5.59 SANUWAVE Health, Inc. Company Overview 160
5.59.1 SANUWAVE Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.60 Sebacia Inc. Company Overview 163
5.60.1 Sebacia Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.61 Sekisui Medical Co., Ltd. Company Overview 166
5.61.1 Sekisui Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 166
5.62 SharpLight Company Overview 167
5.62.1 SharpLight Pipeline Products & Ongoing Clinical Trials Overview 167
5.63 Shin Poong Pharm.Co., Ltd. Company Overview 170
5.63.1 Shin Poong Pharm.Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 170
5.64 Sinclair IS Pharma Plc Company Overview 171
5.64.1 Sinclair IS Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 171
5.65 Slender Medical Ltd. Company Overview 183
5.65.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 183
5.66 Suneva Medical, Inc. Company Overview 184
5.66.1 Suneva Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.67 Sybaritic, Inc. Company Overview 188
5.67.1 Sybaritic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.68 Syneron Medical Ltd. Company Overview 191
5.68.1 Syneron Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 191
5.69 TEI Biosciences, Inc. Company Overview 196
5.69.1 TEI Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.70 ThermiAesthetics Company Overview 197
5.70.1 ThermiAesthetics Pipeline Products & Ongoing Clinical Trials Overview 197
5.71 University of California, Irvine Company Overview 199
5.71.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.72 Valeant Pharmaceuticals Ltd Company Overview 200
5.72.1 Valeant Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 200
5.73 Yolo Medical Inc. Company Overview 201
5.73.1 Yolo Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 201
6 Aesthetic Devices- Recent Developments 203
7 Appendix 310
7.1 Methodology 310
7.2 About GlobalData 312
7.3 Contact Us 313
7.4 Disclaimer 313

1.1 List of Tables
Table 1: Aesthetic Devices - Pipeline Products by Stage of Development 17
Table 2: Aesthetic Devices - Pipeline Products by Segment 18
Table 3: Aesthetic Devices - Pipeline Products by Territory 20
Table 4: Aesthetic Devices - Pipeline Products by Regulatory Path 21
Table 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
Table 6: Aesthetic Devices - Ongoing Clinical Trials 23
Table 7: Aesthetic Devices Companies - Pipeline Products by Stage of Development 24
Table 8: Aesthetic Devices - Pipeline Products by Stage of Development 27
Table 9: Advalight Pipeline Products & Ongoing Clinical Trials Overview 32
Table 10: Yellow Solid State Laser - Skin Rejuvenation - Product Status 32
Table 11: Yellow Solid State Laser - Skin Rejuvenation - Product Description 32
Table 12: Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 33
Table 13: Alluris - Product Status 33
Table 14: Alluris - Product Description 33
Table 15: Skinlumina - Product Status 34
Table 16: Skinlumina - Product Description 34
Table 17: Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 18: Juvence Implant - Product Status 35
Table 19: Juvence Implant - Product Description 35
Table 20: AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 21: AeroForm Patient Controlled Tissue Expander System - Product Status 37
Table 22: AeroForm Patient Controlled Tissue Expander System - Product Description 37
Table 23: AirXpanders, Inc. - Ongoing Clinical Trials Overview 38
Table 24: AeroForm Patient Controlled Tissue Expander System - AeroForm Patient Controlled Tissue Expansion for Breast Reconstruction 39
Table 25: AeroForm Patient Controlled Tissue Expander System - AirXpanders AeroForm Tissue Expander System for Breast Reconstruction (XPAND II) 39
Table 26: Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 27: Eplica Silk - Product Status 41
Table 28: Eplica Silk - Product Description 41
Table 29: JUVEDERM Volbella - Product Status 42
Table 30: JUVEDERM Volbella - Product Description 42
Table 31: JUVEDERM VOLIFT - Product Status 43
Table 32: JUVEDERM VOLIFT - Product Description 43
Table 33: Juvederm VOLUMA XC - Product Status 44
Table 34: Juvederm VOLUMA XC - Product Description 44
Table 35: SeriGel - Product Status 45
Table 36: SeriGel - Product Description 45
Table 37: Allergan, Inc. - Ongoing Clinical Trials Overview 46
Table 38: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin 47
Table 39: Juvederm VOLUMA XC - Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVEDERM VOLUMA XC for the Facial Temporal Regions 47
Table 40: Juvederm VOLUMA XC - Voluma Treatment of HIV Facial Lipoatrophy 47
Table 41: JUVEDERM VOLIFT - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults 48
Table 42: Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
Table 43: Ambulight Rejuvenate - Product Status 49
Table 44: Ambulight Rejuvenate - Product Description 49
Table 45: Lustre Pro - Product Status 50
Table 46: Lustre Pro - Product Description 50
Table 47: Lustre Pure Light Classic - Product Status 51
Table 48: Lustre Pure Light Classic - Product Description 51
Table 49: Andrew Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
Table 50: HydraSolve Lipoplasty System - Visceral Fat - Product Status 52
Table 51: HydraSolve Lipoplasty System - Visceral Fat - Product Description 52
Table 52: Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 53: Next Generation ELEVESS Dermal Filler - Product Status 54
Table 54: Next Generation ELEVESS Dermal Filler - Product Description 54
Table 55: Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 56: ReCell Spray-On Skin - Burns - Product Status 56
Table 57: ReCell Spray-On Skin - Burns - Product Description 56
Table 58: ReNovaCell - Aesthetics And Repigmentation - Product Status 57
Table 59: ReNovaCell - Aesthetics And Repigmentation - Product Description 57
Table 60: Avita Medical Ltd - Ongoing Clinical Trials Overview 58
Table 61: ReCell Spray-On Skin - Burns - A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries 59
Table 62: ReCell Spray-On Skin - Burns - Compassionate Use Investigational Device Exemption (IDE) Program for ReCell 59
Table 63: BioPhotas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 64: Celluma - Periorbital Wrinkles And Rhytides - Product Status 60
Table 65: Celluma - Periorbital Wrinkles And Rhytides - Product Description 60
Table 66: Celluma - Skin Rejuvenation And Sun Spots - Product Status 61
Table 67: Celluma - Skin Rejuvenation And Sun Spots - Product Description 61
Table 68: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 62
Table 69: Matridex - Product Status 63
Table 70: Matridex - Product Description 63
Table 71: Matridur - Product Status 64
Table 72: Matridur - Product Description 64
Table 73: Matrigel - Product Status 65
Table 74: Matrigel - Product Description 65
Table 75: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 76: Airbrush Liposculptor IIE - Product Status 66
Table 77: Airbrush Liposculptor IIE - Product Description 66
Table 78: Airbrush Liposculptor IIIE - Product Status 67

1.2 List of Figures
Figure 1: Aesthetic Devices - Pipeline Products by Stage of Development 17
Figure 2: Aesthetic Devices - Pipeline Products by Segment 18
Figure 3: Aesthetic Devices - Pipeline Products by Territory 19
Figure 4: Aesthetic Devices - Pipeline Products by Regulatory Path 21
Figure 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
Figure 6: Aesthetic Devices - Ongoing Clinical Trials 23

【掲載企業】

Advalight
Aesthetic Medical Device
Aesthetics Point Ltd.
AirXpanders, Inc.
Allergan, Inc.
Ambicare Health Ltd
Andrew Technology, LLC
Anika Therapeutics, Inc.
Avita Medical Ltd
BioPhotas, Inc.
BioPolymer GmbH & Co. KG
Biosculpture Technology, Inc.
Body Organ Biomedical Corp.
Chromogenex Technologies Limited
Cozart plc
Cynosure, Inc.
Cytophil, Inc.
Cytori Therapeutics, Inc.
Cytosial Biomedic, S.a.s.
Dermele Skin Care, LLC
Ellman International, Inc.
Erchonia Corporation
Eternity Healthcare Inc.
EternoGen, LLC
Eve Aesthetics Ltd.
FibroGen, Inc.
Forticell Bioscience, Inc.
Genethia Phrima SRL
Genzyme Corporation
Ilooda Co., Ltd.
ImpLite Ltd.
Innovia LLC
Invasix
Juvenis Ltd.
Keraderm LLC
Khorionyx
L&C Bio
Medifirst Solutions, Inc.
Medixsysteme
Mentor Worldwide LLC
Merz Pharma GmbH & Co. KgaA
Moma Therapeutics, Inc.
Mosaic Medical Technologies, Inc
Neosthetic, LLC
NivaSonix, LLC
Northwestern University
Northwood Medical Innovation Limited
Nu Skin International Inc.
Oligo Medic, Inc.
ORGEV Laboratories
Osyris Medical
Philips Healthcare
PhotoDerma SA
PhotoMedex, Inc.
Pinnacle Therapeutics
PolyNovo Biomaterials Pty Ltd
PS Advanced Engineering
Rocky Mountain Biosystems Inc
SANUWAVE Health, Inc.
Sebacia Inc.
Sekisui Medical Co., Ltd.
SharpLight
Shin Poong Pharm.Co., Ltd.
Sinclair IS Pharma Plc
Slender Medical Ltd.
Suneva Medical, Inc.
Sybaritic, Inc.
Syneron Medical Ltd.
TEI Biosciences, Inc.
ThermiAesthetics
University of California, Irvine
Valeant Pharmaceuticals Ltd
Yolo Medical Inc.

【レポートのキーワード】

美容機器

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の美容機器開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月24日現在 190,338 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆